Patients' genetics shape response to GLP1 drugs
Two genetic variants affect the response to glucagon-like peptide 1 (GLP-1) receptor agonists drugs, according to a new large-scale study by the 23andMe Research Institute...
Two genetic variants affect the response to glucagon-like peptide 1 (GLP-1) receptor agonists drugs, according to a new large-scale study by the 23andMe Research Institute...
by BioNews
by Iona Aylwin
The Scottish Government has launched newborn screening for spinal muscular atrophy, allowing earlier diagnosis and access to potentially life-changing treatment...
by Charlotte Grey and 1 others
The most recent PET event took place in Edinburgh and brought together researchers, clinicians and members of the public to examine advances in understanding and treating male infertility...
Epigenetic changes in colon cells caused by colitis can increase susceptibility to developing colorectal cancer in the future...
by Yan Lau
A gene normally active only in reproductive cells may drive genetic instability in aggressive breast cancers, offering a potential new treatment target...
A gene that normally ensures sperm quality in fruit flies can be hijacked by 'selfish chromosomes' to bias inheritance, showing how some genetic elements determine which sperm survive...
In this two-part conversation, Dr Philip Ball and Dr Naomi Moris explore the intersection of philosophy and developmental biology, discussing stem-cell-based embryo models and ethical questions raised by emerging research...
by Dr Teja Rus
Human stem cells edited to evade immune responses survived for five months in mice without triggering rejection...
An artificial intelligence model trained on genomic data can predict disease-causing mutations and design synthetic viruses...
Subscribe for free to what PET does best – informing you of the latest in fertility, genomics and embryo research.